Morgan Stanley 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-09 4:50 pm Sale | 2021-03-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | MORGAN STANLEY MS | 577,022 1.800% | -416,601 (-41.93%) | Filing |
| 2021-02-12 3:59 pm Purchase | 2020-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | MORGAN STANLEY MS | 993,623 5.700% | 112,185 (+12.73%) | Filing |
| 2020-12-18 4:27 pm Purchase | 2020-12-11 | 13G | Satsuma Pharmaceuticals, Inc. STSA | MORGAN STANLEY MS | 881,438 5.100% | 881,438 (New Position) | Filing |